 |
|
|
| |
A Case Series on Outcomes of Hepatitis C Infected Patients Who Received Full Course of 84 Tablets of Sofosbuvir/Velpatasvir at the Beginning of Therapy
|
| |
| |
AASLD 2026 Denver
Amy Seale1, Farrah Black2, Stacey Scherbakovsky2
1. Our Lady of the Angels, Bogalusa, LA, USA 2. Gilead Sciences Inc., Foster City, CA, USA
|
| |
|
|
|
|
|
